Eczema Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People aged 6 to 65 years old (male or female)
• People who have been diagnosed with atopic dermatitis (eczema) according to standard medical diagnostic criteria

Who may not be able to join:

• People who are already enrolled in another clinical trial
• People who have a known allergy or sensitivity to any product used in the skin decolonisation process used in this trial (confirm with trial site)
• People who have used immune-suppressing or immune-modifying medications — such as corticosteroids, cyclosporine, mycophenolate, JAK inhibitors, azathioprine, or methotrexate — within the past 4 weeks
• People who have had light therapy (phototherapy) for eczema within the past 4 weeks
• People who have been treated with certain biologic medicines (such as dupilumab, omalizumab, or benralizumab) within the past 16 weeks
• People who have used topical (applied to the skin) steroids, topical calcineurin inhibitors, or crisaborole within the past 7 days
• People who have taken bleach baths within the 7 days before the first visit
• People who have used antibiotic medications — either oral or topical — within the past 21 days
• People with asthma who are taking more than 500 micrograms per day of inhaled corticosteroids
• People with a history of HIV, hepatitis B, hepatitis C, tuberculosis, or cancer
• People with other skin conditions that may affect how results are measured, such as psoriasis or cutaneous T-cell lymphoma
• People with serious ongoing health conditions, such as heart disease, kidney disease, or autoimmune disease
• People who have a fever or febrile illness at the time of their visits
• People with a suspected immune system deficiency, or a family history of a primary immune deficiency condition

Important: Always verify eligibility with the trial site directly before applying.